These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20731771)

  • 1. Oral furosemide-induced natriuresis: a potential method for identifying cirrhotic patients with refractory ascites.
    Kountouras J; Zavos C; Touloumis L; Chatzopoulos D
    Liver Int; 2010 Oct; 30(9):1395; author reply 1395-6. PubMed ID: 20731771
    [No Abstract]   [Full Text] [Related]  

  • 2. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
    Spahr L; Villeneuve JP; Tran HK; Pomier-Layrargues G
    Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory ascites: can it be defined only by the response to furosemide and spironolactone?
    Kalambokis G; Tsianos EV
    Liver Int; 2010 Oct; 30(9):1394; author reply 1395-6. PubMed ID: 20738777
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
    Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
    Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ascites complicating cirrhosis].
    Valla DC
    Rev Prat; 1997 Mar; 47(5):491-6. PubMed ID: 9138410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory ascites: definition and mechanism.
    Arroyo V; Badalamenti S; Ginès P
    Minerva Med; 1987 May; 78(10):675-80. PubMed ID: 3587714
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis and therapy of ascites in liver cirrhosis].
    Nilius R
    Gastroenterol J; 1991; 51(3-4):97-102. PubMed ID: 1811663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites.
    Tuttolomondo A; Pinto A; Parrinello G; Licata G
    Semin Nephrol; 2011 Nov; 31(6):513-22. PubMed ID: 22099508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites.
    Misra VL; Vuppalanchi R; Jones D; Hamman M; Kwo PY; Kahi C; Chalasani N
    Aliment Pharmacol Ther; 2010 Oct; 32(8):1044-50. PubMed ID: 20937051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory ascites: definition, pathogenesis and treatment.
    Laffi G; La Villa G; Pinzani M; Foschi M; Carloni V; Casini Raggi V; Gentilini P
    Ann Ital Med Int; 1993; 8(1):38-46. PubMed ID: 8485009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of diuretics in the treatment of cirrhotic ascites.
    Boyer TD; Warnock DG
    Gastroenterology; 1983 May; 84(5 Pt 1):1051-5. PubMed ID: 6832557
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites.
    Tuttolomondo A; Di Raimondo D; Bellia C; Clemente G; Pecoraro R; Maida C; Simonetta I; Vassallo V; Di Bona D; Gulotta E; Ciaccio M; Pinto A
    PLoS One; 2016; 11(12):e0165443. PubMed ID: 27941973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol in the treatment of cirrhotic ascites.
    Rector WG; Reynolds TB
    Arch Intern Med; 1984 Sep; 144(9):1761-3. PubMed ID: 6476994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of ascites in liver cirrhosis].
    Gramkow M; Christensen E
    Ugeskr Laeger; 1994 Sep; 156(37):5256-65. PubMed ID: 7941060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.
    Therapondos G; Hol L; Benjaminov F; Wong F
    Hepatology; 2006 Sep; 44(3):640-9. PubMed ID: 16941706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of the furosemide test for predicting ascites control by diuretics in cirrhotics: a comparison with volume expansion and octreotide infusion.
    Toniutto P; Pirisi M; Fabris C; Apollonio L; Sereti K; Bartoli EG
    Dig Dis Sci; 2006 Nov; 51(11):1992-7. PubMed ID: 17053959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.